Cleared Traditional

LUBRICANT, OTRHO PERSONAL (K790087) - FDA 510(k) Clearance

Class I General Hospital device.

K790087 · Ortho Pharmaceutical Corp. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1979
Decision
15d
Days
Class 1
Risk

K790087 is an FDA 510(k) clearance for the LUBRICANT, OTRHO PERSONAL. Classified as Lubricant, Patient (product code KMJ), Class I - General Controls.

Submitted by Ortho Pharmaceutical Corp. (Walker, US). The FDA issued a Cleared decision on February 1, 1979 after a review of 15 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.6375 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Ortho Pharmaceutical Corp. devices

Submission Details

510(k) Number K790087 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 17, 1979
Decision Date February 01, 1979
Days to Decision 15 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
114d faster than avg
Panel avg: 129d · This submission: 15d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code KMJ Lubricant, Patient
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 880.6375
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.